Prosecution Insights
Last updated: September 17, 2026
Application No. 19/264,643

FENESTRATION TEMPLATE FOR ENDOVASCULAR REPAIR OF AORTIC ANEURYSMS

Non-Final OA §102§112
Filed
Jul 09, 2025
Priority
Mar 10, 2021 — divisional of 12/377,609
Examiner
JAMIALAHMADI, MAJID
Art Unit
Tech Center
Assignee
University Of Washington Through It'S Center For Commercialization
OA Round
1 (Non-Final)
74%
Grant Probability
Favorable
1-2
OA Rounds
1y 11m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 74% — above average
74%
Career Allowance Rate
299 granted / 403 resolved
+14.2% vs TC avg
Strong +58% interview lift
Without
With
+57.5%
Interview Lift
resolved cases with interview
Typical timeline
3y 1m
Avg Prosecution
16 currently pending
Career history
421
Total Applications
across all art units

Statute-Specific Performance

§101
0.6%
-39.4% vs TC avg
§103
43.0%
+3.0% vs TC avg
§102
28.0%
-12.0% vs TC avg
§112
23.1%
-16.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 403 resolved cases

Office Action

§102 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-5 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor, or for pre-AIA the applicant regards as the invention. Regarding claim 1, the claim recites the limitations “The fenestration template device” in line 1. There is insufficient antecedent basis for this limitation in the claim. Appropriate correction is required. Regarding claim 4, the claim recites the limitations “the stent graft”. There is insufficient antecedent basis for this limitation in the claim. Appropriate correction is required. Claims 2-3 and 5 are rejected due to being dependent on claim 1. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-5 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Taylor (US Pub No. 2004/0116997). Regarding claim 1, Taylor discloses (Figures 1-26) the fenestration template device (Figure 1) for an aortic graft [Not positively recited in the claim and is only functionally recited], comprising: a physical model (10) representing a section of a patient's aorta having one or more branch vessel openings (Figure 4) (Paragraphs 0062-0065 and 0097-0101), the physical model comprising a wall defining a lumen (22) and having one or more openings (openings of 15, 16 and 18) (Figures 1-2) in the wall representing the one or more branch vessel openings of the patient's aorta (Figure 4) (Paragraphs 0062-0065 and 0097-0101). Regarding claim 2, wherein the physical model is generated using a three- dimensional (3-D) printing technology (Paragraph 0100). Regarding claim 3, wherein the physical model is generated based at least in part on a 3-D digital model of the patient's aorta (Paragraphs 0097-0100). Regarding claim 4, wherein the one or more openings in the wall are indicative of locations of one or more fenestrations on the stent graft when the fenestration template device is coupled with the aortic graft [Since Taylor discloses all of the structural elements in the same arrangement as claimed and also, the stent graft is not positively recited in the claim and is only functionally recited, then the template device of Talor is fully capable in being used so that the one or more openings in the wall of the template are indicative of locations of one or more fenestrations on the stent graft when the fenestration template device is coupled with the aortic graft]. Regarding claim 5, wherein the physical model is disposable [Fully capable of being disposed]. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to MAJID JAMIALAHMADI whose telephone number is (571) 270-0172. The examiner can normally be reached on Monday-Friday 7am-5pm EST. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Darwin Erezo can be reached on (571) 272-4695. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MAJID JAMIALAHMADI/Primary Examiner, Art Unit 3771
Read full office action

Prosecution Timeline

Jul 09, 2025
Application Filed
Sep 01, 2026
Non-Final Rejection mailed — §102, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12733920
FIXATION DEVICE, IMPLANT AND IMPLANT ASSEMBLY FOR USE IN TISSUE REPAIR
3y 9m to grant Granted Sep 15, 2026
Patent 12734072
Ear Cleaner Device
1y 9m to grant Granted Sep 15, 2026
Patent 12728076
PACIFIER
3y 8m to grant Granted Sep 08, 2026
Patent 12727914
CATHETER EXTRACTION
2y 6m to grant Granted Sep 08, 2026
Patent 12721753
Single-Handed Electrosurgical Device And Methods Thereof
3y 4m to grant Granted Sep 01, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
74%
Grant Probability
99%
With Interview (+57.5%)
3y 1m (~1y 11m remaining)
Median Time to Grant
Low
PTA Risk
Based on 403 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month